Safety, Efficacy, and Preventive Role of Subcutaneous and Sublingual Allergen Immunotherapy for the Treatment of Pediatric Asthma

References

• Global Initiative for Asthma. Global initiative for asthma: global strategy for asthma management and prevention, 2020; 2020 Available from: https://ginasthma.org/gina-reports/. Accessed 87, 2020.
   Google Scholar
• Accordini S, Corsico AG, Calciano L, et al. The impact of asthma, chronic bronchitis and allergic rhinitis on all-cause hospitalizations and limitations in daily activities: a population-based observational study. BMC Pulm Med. 2015;15:10. doi:10.1186/s12890-015-0008-025880039
   PubMed Web of Science ®Google Scholar
• Kuruvilla ME, Lee FE, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219–233. doi:10.1007/s12016-018-8712-130206782
   PubMed Web of Science ®Google Scholar
• Mastrorilli C, Posa D, Cipriani F, Caffarelli C. Asthma and allergic rhinitis in childhood: what’s new. Pediatr Allergy Immunol. 2016;27(8):795–803. doi:10.1111/pai.1268127862336
   PubMed Web of Science ®Google Scholar
• Chipps BE, Bacharier LB, Murphy KR, et al. The asthma controller step-down yardstick. Ann Allergy Asthma Immunol. 2019;122(3):241–262.e4. doi:10.1016/j.anai.2018.12.00430550809
   PubMed Web of Science ®Google Scholar
• Cipriani F, Mastrorilli C, Tripodi S, et al. Diagnostic relevance of IgE sensitization profiles to eight recombinant Phleum pratense molecules. Allergy. 2018;73(3):673–682. doi:10.1111/all.1333829055045
   PubMed Web of Science ®Google Scholar
• Caffarelli C, Garrubba M, Greco C, Mastrorilli C, Povesi Dascola C. Asthma and food allergy in children: is there a connection or interaction? Front Pediatr. 2016;4:34. doi:10.3389/fped.2016.0003427092299
   PubMed Web of Science ®Google Scholar
• Roberts G, Pfaar O, Akdis CA, et al. EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73(4):765–798.28940458
   PubMed Web of Science ®Google Scholar
• Alvaro-Lozano M, Akdis CA, Akdis M, et al. EAACI allergen immunotherapy user’s guide. Pediatr Allergy Immunol. 2020;31(Suppl 25):1–101. doi:10.1111/pai.1318932436290
   PubMed Web of Science ®Google Scholar
• Di Rienzo V, Cadario G, Grieco T, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, open, parallel-group study. Ann Allergy Asthma Immunol. 2014;113(6):671–673. doi:10.1016/j.anai.2014.09.00925304342
   PubMed Web of Science ®Google Scholar
• Nurmatov U, Dhami S, Arasi S. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis. Allergy. 2017;72(8):1133–1147. doi:10.1111/all.1312428058751
   PubMed Web of Science ®Google Scholar
• Noon L, Cantar BO. Prophylactic inoculation against hay fever. Lancet. 1911;1:1572–1573.
   Google Scholar
• Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Exp Allergy. 1986;16(5):483–491. doi:10.1111/j.1365-2222.1986.tb01983.x
   Web of Science ®Google Scholar
• Warner JO. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy. 1986;16(5):387–388. doi:10.1111/j.1365-2222.1986.tb01973.x3779937
   PubMedGoogle Scholar
• Okamoto Y, Fujieda S, Okano M, Hida H, Kakudo S, Masuyama K. Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: a randomized trial in a pediatric population. Pediatr Allergy Immunol. 2019;30(1):66–73. doi:10.1111/pai.1298430281866
   PubMed Web of Science ®Google Scholar
• EMA European Medicine Agency. Committee for medicinal products for human use (CHMP). Guideline on allergen products: production and quality issues. EMEA/CHMP/BWP/304831/2007; 2008 Available from: https://www.ema.europa.eu/en/allergen-products-production-quality-issues. Accessed 828, 2020.
   Google Scholar
• Jacobsen L, Wahn U, Bilo MB. Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy. Clin Transl Allergy. 2012;2:8. doi:10.1186/2045-7022-2-822500494
   PubMedGoogle Scholar
• Casset A, Mari A, Purohit A, et al. Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol. 2012;159(3):253–262. doi:10.1159/00033765422722650
   PubMed Web of Science ®Google Scholar
• Moreno Benítez F, Espinazo Romeu M, Letrán Camacho A, Mas S, García-Cózar FJ, Tabar AI. Variation in allergen content in sublingual allergen immunotherapy with house dust mites. Allergy. 2015;70(11):1413–1420. doi:10.1111/all.1269426185961
   PubMed Web of Science ®Google Scholar
• Pfaar O, Agache I, de Blay F, et al. Perspectives in allergen immunotherapy: 2019 and beyond. Allergy. 2019;74(Suppl 108):3–25. doi:10.1111/all.14077
   PubMed Web of Science ®Google Scholar
• Novak N, Bieber T, Allam JP. Immunological mechanisms of sublingual allergen-specific immunotherapy. Allergy. 2011;66(6):733–739. doi:10.1111/j.1398-9995.2010.02535.x21251016
   PubMed Web of Science ®Google Scholar
• Moingeon P. Update on immune mechanisms associated with sublingual immunotherapy: practical implications for the clinician. J Allergy Clin Immunol Pract. 2013;1(3):228–241. doi:10.1016/j.jaip.2013.03.01324565479
   PubMed Web of Science ®Google Scholar
• Akdis CA, Akdis M. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J. 2015;8(1):1–12. doi:10.1186/s40413-015-0063-225709746
   PubMed Web of Science ®Google Scholar
• Eberlein-König B, Ullmann S, Thomas P, Przybilla B. Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization. Clin Exp Allergy. 1995;25(8):704–712.7584681
   PubMed Web of Science ®Google Scholar
• Shamji MH, Layhadi JA, Scadding GW, et al. Basophil expression of diamine oxidase: a novel biomarker of allergen immunotherapy response. J Allergy Clin Immunol. 2015;135(4):913–921. doi:10.1016/j.jaci.2014.09.04925457150
   PubMed Web of Science ®Google Scholar
• Novak N, Mete N, Bussmann C, et al. Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol. 2012;130(5):1153–1158. doi:10.1016/j.jaci.2012.04.03922698521
   PubMed Web of Science ®Google Scholar
• He YT, Zhou Y, Shao Q, et al. Immunoregulatory effects of subcutaneous immunotherapy on lymphocyte subgroups and cytokines in children with asthma. J Immunol Res. 2019;2019:7024905. doi:10.1155/2019/702490531737687
   PubMed Web of Science ®Google Scholar
• Caffarelli C, Cangemi J, Mastrorilli C, Giannetti A, Ricci G. Allergen-specific immunotherapy for inhalant allergens in children. Curr Pediatr Rev. 2020;16(2):129–139. doi:10.2174/157339631566619102110400331642784
   PubMed Web of Science ®Google Scholar
• Cuppari C, Leonardi S, Manti S, et al. Allergen immunotherapy, routes of administration and cytokine networks: an update. Immunotherapy. 2014;6(6):775–786. doi:10.2217/imt.14.4725186606
   PubMed Web of Science ®Google Scholar
• Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 Suppl):S1–S55. doi:10.1016/j.jaci.2010.09.03421122901
   PubMed Web of Science ®Google Scholar
• Calderón MA, Cox L, Casale TB, Moingeon P, Demoly P. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol. 2012;129(4):929–934. doi:10.1016/j.jaci.2011.11.01922244595
   PubMed Web of Science ®Google Scholar
• Calderón MA, Simons FE, Malling HJ, Lockey RF, Moingeon P, Demoly P. Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile. Allergy. 2012;67(3):302–311. doi:10.1111/j.1398-9995.2011.02761.x22150126
   PubMed Web of Science ®Google Scholar
• Pitsios C, Tsoumani M, Bilò MB, et al. Contraindications to immunotherapy: a global approach. Clin Transl Allergy. 2019;9:45. doi:10.1186/s13601-019-0285-431528333
   PubMed Web of Science ®Google Scholar
• Jutel M, Agache I, Bonin S, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556–568. doi:10.1016/j.jaci.2015.04.04726162571
   PubMed Web of Science ®Google Scholar
• Temino VM, Wu P, Konig J, Fahrenholz JM. Safety of multiple aeroallergen rush immunotherapy using a modified schedule. Allergy Asthma Proc. 2013;34(3):255–260. doi:10.2500/aap.2013.34.365123676574
   PubMed Web of Science ®Google Scholar
• Aaronson DW, Gandhi TK. Incorrect allergy injections: allergists’ experiences and recommendations for prevention. J Allergy Clin Immunol. 2004;113(6):1117–1121. doi:10.1016/j.jaci.2004.01.75615208593
   PubMed Web of Science ®Google Scholar
• Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: the World Allergy Organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol. 2010;125(3):569–74, 574. doi:10.1016/j.jaci.2009.10.06020144472
   PubMed Web of Science ®Google Scholar
• Petalas K, Durham SR. Allergen immunotherapy for allergic rhinitis. Rhinology. 2013;51(2):99–110.23671890
   PubMed Web of Science ®Google Scholar
• Rice JL, Diette GB, Suarez-Cuervo C, et al. Allergen-specific immunotherapy in the treatment of pediatric asthma: a systematic review. Pediatrics. 2018;141(5):e20173833. doi:10.1542/peds.2017-383329572287
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim SC, Choi H, et al. A retrospective study of clinical response predictors in subcutaneous allergen immunotherapy with house dust mites for allergic rhinitis. Allergy Asthma Immunol Res. 2018;10(1):18–24. doi:10.4168/aair.2018.10.1.1829178674
   PubMed Web of Science ®Google Scholar
• Schiappoli M, Ridolo E, Senna G, et al. A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. Clin Exp Allergy. 2009;39(10):1569–1574. doi:10.1111/j.1365-2222.2009.03286.x19486027
   PubMed Web of Science ®Google Scholar
• Dunsky EH, Goldstein MF, Dvorin DJ, Belecanech GA. Anaphylaxis to sublingual immunotherapy. Allergy. 2006;61(10):1235. doi:10.1111/j.1398-9995.2006.01137.x16942576
   PubMed Web of Science ®Google Scholar
• Vovolis V, Kalogiros L, Mitsias D, Sifnaios E. Severe repeated anaphylactic reactions to sublingual immunotherapy. Allergol Immunopathol (Madr). 2013;41(4):279–281. doi:10.1016/j.aller.2012.05.01223253689
   PubMed Web of Science ®Google Scholar
• Nelson HS. Multiallergen immunotherapy for allergic rhinitis and asthma. J Allergy Clin Immunol. 2009;123(4):763–769.19217653
   PubMed Web of Science ®Google Scholar
• Cox LS, Larenas Linnemann D, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006;117(5):1021–1035. doi:10.1016/j.jaci.2006.02.04016675328
   PubMed Web of Science ®Google Scholar
• Mastrorilli C, Cardinale F, Giannetti A, Caffarelli C. Pollen-food allergy syndrome: a not so rare disease in childhood. Medicina (Kaunas). 2019;55(10):641. doi:10.3390/medicina55100641
   Web of Science ®Google Scholar
• Larenas-Linnemann D, Blaiss M, Van Bever HP, Compalati E, Baena-Cagnani CE. Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009–2012. Ann Allergy Asthma Immunol. 2013;110(6):402–415.e9. doi:10.1016/j.anai.2013.02.01723706708
   PubMed Web of Science ®Google Scholar
• Miehlke S, Alpan O, Schröder S, Straumann A. Induction of eosinophilic esophagitis by sublingual pollen immunotherapy. Case Rep Gastroenterol. 2013;7(3):363–368. doi:10.1159/00035516124163646
   PubMedGoogle Scholar
• Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017;72(11):1597–1631.28493631
   PubMed Web of Science ®Google Scholar
• Lu Y, Xu L, Xia M, Li Y, Cao L. The efficacy and safety of subcutaneous immunotherapy in mite-sensitized subjects with asthma: A meta-analysis. Respir Care. 2015;60(2):269–278. doi:10.4187/respcare.0339925389355
   PubMed Web of Science ®Google Scholar
• Di Bona D, Frisenda F, Albanesi M, Di Lorenzo G, Caiaffa MF, Macchia L. Efficacy and safety of allergen immunotherapy in patients with allergy to molds: a systematic review. Clin Exp Allergy. 2018;48(11):1391–1401. doi:10.1111/cea.1324230079619
   PubMed Web of Science ®Google Scholar
• Cools M, Van Bever HP, Weyler JJ, et al. Long-term effects of specific immunotherapy, administered during childhood, in asthmatic patients allergic to either house-dust mite or to both house-dust mite and grass pollen. Allergy. 2000;55(1):69–73. doi:10.1034/j.1398-9995.2000.00191.x10696859
   PubMed Web of Science ®Google Scholar
• Stelmach I, Sobocińska A, Majak P, Smejda K, Jerzyńska J, Stelmach W. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy. Ann Allergy Asthma Immunol. 2012;109(4):274–278. doi:10.1016/j.anai.2012.07.01523010234
   PubMed Web of Science ®Google Scholar
• Pifferi M, Baldini G, Marrazzini G, et al. Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study. Allergy. 2002;57(9):785–790. doi:10.1034/j.1398-9995.2002.23498.x12169173
   PubMed Web of Science ®Google Scholar
• Zielen S, Kardos P, Madonini E. Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial. J Allergy Clin Immunol. 2010;126(5):942–949. doi:10.1016/j.jaci.2010.06.00220624650
   PubMed Web of Science ®Google Scholar
• Tsai TC, Lu JH, Chen SJ, et al. Clinical efficacy of house dust mite-specific immunotherapy in asthmatic children. Pediatr Neonatol. 2010;51(1):14–18. doi:10.1016/S1875-9572(10)60004-620225533
   PubMed Web of Science ®Google Scholar
• Chen ZG, Li M, Chen YF, et al. Effects of dermatophagoides pteronyssinus allergen-specific immunotherapy on the serum interleukin-13 and pulmonary functions in asthmatic children. Chin Med J (Engl). 2009;122(10):1157–1161.19493463
   PubMed Web of Science ®Google Scholar
• Ibero M, Castillo MJ. Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of Dermatophagoides pteronyssinus. J Investig Allergol Clin Immunol. 2006;16(3):194–202.
   PubMed Web of Science ®Google Scholar
• Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study. Int Arch Allergy Immunol. 2012;157(3):288–298. doi:10.1159/00032756622041501
   PubMed Web of Science ®Google Scholar
• Alzakar RH, Alsamarai AM. Efficacy of immunotherapy for treatment of allergic asthma in children. Allergy Asthma Proc. 2010;31(4):324–330. doi:10.2500/aap.2010.31.335320819323
   PubMed Web of Science ®Google Scholar
• Wahn U, Bachert C, Heinrich J, Richter H, Zielen S. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma. Allergy. 2019;74(3):594–604. doi:10.1111/all.1359830183091
   PubMed Web of Science ®Google Scholar
• Möller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-Study). J Allergy Clin Immunol. 2002;109(2):251–256. doi:10.1067/mai.2002.12131711842293
   PubMed Web of Science ®Google Scholar
• Niggemann B, Jacobsen L, Dreborg S, et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy. 2006;61(7):855–859. doi:10.1111/j.1398-9995.2006.01068.x16792584
   PubMed Web of Science ®Google Scholar
• Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62(8):943–948. doi:10.1111/j.1398-9995.2007.01451.x17620073
   PubMed Web of Science ®Google Scholar
• Lin SY, Azar A, Suarez-Cuervo C, et al. Role of sublingual immunotherapy in the treatment of asthma: an updated systematic review. Int Forum Allergy Rhinol. 2018;8(9):982–992.29885036
   PubMed Web of Science ®Google Scholar
• Penagos M, Passalacqua G, Compalati E, et al. Meta-analysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest. 2008;133(3):599–609. doi:10.1378/chest.06-142517951626
   PubMed Web of Science ®Google Scholar
• Olaguíbel JM, Álvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J Investig Allergol Clin Immunol. 2005;15(1):9–16.
   PubMed Web of Science ®Google Scholar
• Liao W, Hu Q, Shen LL, et al. Sublingual immunotherapy for asthmatic children sensitized to house dust mite: A meta-analysis. Medicine (Baltimore). 2015;94(24):e701. doi:10.1097/MD.000000000000070126091451
   PubMed Web of Science ®Google Scholar
• Compalati E, Passalacqua G, Bonini M, Canonica GW. The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis. Allergy. 2009;64(11):1570–1579. doi:10.1111/j.1398-9995.2009.02129.x19796205
   PubMed Web of Science ®Google Scholar
• Stelmach I, Kaluzińska-Parzyszek I, Jerzynska J, Stelmach P, Stelmach W, Majak P. Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children. Allergy Eur J Allergy Clin Immunol. 2012;67(3):312–320. doi:10.1111/j.1398-9995.2011.02758.x
   Web of Science ®Google Scholar
• Majak P, Kaczmarek-Woźniak J, Brzozowska A, Bobrowska-Korzeniowska M, Jerzynska J, Stelmach I. One-year follow-up of clinical and inflammatory parameters in children allergic to grass pollen receiving high-dose ultrarush sublingual immunotherapy. J Investig Allergol Clin Immunol. 2010;20(7):602–606.
   Web of Science ®Google Scholar
• Calamita Z, Saconato H, Pelá AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy. 2006;61(10):1162–1172. doi:10.1111/j.1398-9995.2006.01205.x16942563
   PubMed Web of Science ®Google Scholar
• Normansell R, Kew KM, Bridgman AL. Sublingual immunotherapy for asthma. Cochrane Database Syst Rev. 2015;28(8):CD011293.s.
   Google Scholar
• Di Rienzo V, Marcucci F, Puccinelli P, et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: A 10-year prospective study. Clin Exp Allergy. 2003;33(2):206–210. doi:10.1046/j.1365-2222.2003.01587.x12580913
   PubMed Web of Science ®Google Scholar
• Marogna M, Spadolini I, Massolo A, Canonica GW, Passalacqua G. Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol. 2010;126(5):969–975.20934206
   PubMed Web of Science ®Google Scholar
• Tahamiler R, Saritzali G, Canakcioglu S, et al. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis. Laryngoscope. 2007;117(6):965–969. doi:10.1097/MLG.0b013e31804f814117545861
   PubMed Web of Science ®Google Scholar
• Ozdemir C, Yazi D, Gocmen I, et al. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol. 2007;18(6):508–515. doi:10.1111/j.1399-3038.2007.00549.x17680909
   PubMed Web of Science ®Google Scholar
• Eifan AO, Akkoc T, Yildiz A, et al. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy. 2010;40(6):922–932. doi:10.1111/j.1365-2222.2009.03448.x20100188
   PubMed Web of Science ®Google Scholar
• Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2004;114(4):851–857. doi:10.1016/j.jaci.2004.07.01215480326
   PubMed Web of Science ®Google Scholar
• Valovirta E, Petersen TH, Piotrowska T, et al. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol. 2018;141(2):529–538.e13. doi:10.1016/j.jaci.2017.06.01428689794
   PubMed Web of Science ®Google Scholar
• Devillier P, Molimard M, Ansolabehere X, et al. Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: a retrospective database study in France. Allergy. 2019;74(7):1317–1326.30589088
   PubMed Web of Science ®Google Scholar
• Zielen S, Devillier P, Heinrich J, Richter H, Wahn U. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis. Allergy. 2018;73(1):165–177. doi:10.1111/all.1321328561266
   PubMed Web of Science ®Google Scholar